1. Home
  2. CGEM vs AXG Comparison

CGEM vs AXG Comparison

Compare CGEM & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$11.84

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

AXG

Solowin Holdings Class A Ordinary Share

N/A

Current Price

$3.99

Market Cap

790.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CGEM
AXG
Founded
2016
2021
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
790.2M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CGEM
AXG
Price
$11.84
$3.99
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$28.13
N/A
AVG Volume (30 Days)
707.4K
764.9K
Earning Date
02-26-2026
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,656,000.00
Revenue This Year
N/A
$28.53
Revenue Next Year
N/A
$54.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.49
52 Week Low
$5.68
$1.16
52 Week High
$13.33
$5.09

Technical Indicators

Market Signals
Indicator
CGEM
AXG
Relative Strength Index (RSI) 57.77 47.48
Support Level $11.53 $4.00
Resistance Level $12.99 $4.19
Average True Range (ATR) 0.76 0.28
MACD 0.12 -0.05
Stochastic Oscillator 61.36 15.29

Price Performance

Historical Comparison
CGEM
AXG

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About AXG Solowin Holdings Class A Ordinary Share

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: